Neuroprotective effects of fingolimod following traumatic brain injury (TBI) and other neurodegenerative disease has also been shown to be correlated with activation of the PI3K/Akt pathway [74, 75]. This evidence concerns the gene AKT1 and neurodegenerative disease.